7th DCVA NLHI Translational Cardiovascular Research Meeting

We are pleased to inform you that the 7th DCVA NLHI Translational Cardiovascular Research Meeting will take place on Thursday 22 June and Friday 23 June 2023. We are looking forward to meeting you!

On this page you can find more information about the registration proces, the program outline and the different prizes that will be awarded during the 7th DCVA NLHI Translational Cardiovascular Research Meeting.

Would you like to know more about the congress? Check out the congress website or the aftermovie of last years DCVA NLHI Translational Cardiovsacular Research Meeting for an impression.

Thursday, June 22

12:30 registration
13:30 opening
13:40 5 years DCVA
16:50 NLHI fellowships competition
18:00 Start walking network dinner
21:00 end

Friday, June 23

8:00 registration
8:30 opening
8:45 Einthoven dissertation competition
12:25 LUNCH
16:15 closing session
Double Dose fellowship competition
Awarding sessions
Wiek van Gilst Award
17:30 end, drinks

Registration is still open for the 7th DCVA-NLHI Translational Cardiovascular Research Meeting. We are excited to announce that our Friday sessions are completely booked! However, we still have a few spots left for Thursday

Reserve your spot HERE- space is limited!

We are thrilled to announce our Keynote Speakers who will be sharing their expertise and insights with us. Get ready for a truly inspiring and informative event!

1️⃣ Anke Vervoord 🎙️ Join us in welcoming Anke Vervoord, the Managing Director of Harteraad. Anke is the Managing Director of the Harteraad, the Dutch patient association for people with heart and vascular diseases and the people they love. Her extensive experience in patient advocacy and dedication to improving the lives of those affected make her talk a must-attend event!

2️⃣ Prof. dr. John Kastelein 🎙️ Prepare to be amazed by the knowledge and expertise of Prof. dr. John Kastelein, Emeritus professor of Medicine, previous chair of the Department of Vascular Medicine, AMC, University of Amsterdam.

John Kastelein is emeritus professor of Medicine, co-founder of UniQure and Xenon, both Nasdaq listed Biotech companies and currently is founder and Chief Science Officer (CSO) of NewAmsterdam Pharma, which received a Nasdaq listing in January of 2023. Valorisation of scientific ideas into Biotech companies is the specialty and the lifetime work of prof Kastelein, which makes his lecture a go-to event!

3️⃣ Prof. dr. Sjoerd Repping 🎙️– Professor of Sensible Care at the University of Amsterdam (UvA) and Chair of ZE&GG (Care Evaluation and Appropriate Use) program at Zorginstituut Nederland.

Sjoerd Repping leads the Care Evaluation and Appropriate Use program at Zorginstituut Nederland. Together with the Dutch Healthcare Authority, this organization investigates how healthcare can continue to improve and remain accessible to everyone in the Netherlands. Repping's goal is to make hospital care increasingly scientifically based. Get ready to gain valuable knowledge from his expertise!

4️⃣ Dr. Chahinda Ghossein-Doha 🎙️ Get ready to be inspired by the passion and dedication of Dr. Chahinda Ghossein-Doha, a cardiologist and researcher specializing in women's specific health. Through her research and her foundation, Queen of Hearts, she tirelessly advocates for women's cardiovascular health. Her talk will shed light on crucial issues and empower us to make a difference.

5️⃣ Prof. dr. Chris Gale 🎙️- Professor of Cardiovascular Medicine, Honorary Consultant Cardiologist, and Co-Director of the Leeds Institute for Data Analytics at the University of Leeds.

We are thrilled to have Prof. dr. Chris Gale, an esteemed Professor of Cardiovascular Medicine, as one of our distinguished speakers. Professor Gale’s research incorporates the efficient use of observational and randomised data to deliver population-based studies of cardiovascular quality of care and clinical outcomes. With his expertise and role as Co-Director of the Leeds Institute for Data Analytics, Prof. Gale will share invaluable insights which will make his talk a must-attend event!

6️⃣ Prof. Dr. Hester den Ruijter 🎙️- Professor of Cardiovascular Disease in Women at the UMC Utrecht.

Join us in welcoming Prof. Dr. Hester den Ruijter, a leading expert in Cardiovascular Disease in Women. Her main focus is to translate knowledge from experimental research to the patient. Professor den Ruijter is doing scientific research on the difference in cardiovascular disease between men and women, with special attention to the female heart. Get ready to gain valuable knowledge from her expertise!


Chair: Daniël Pijnappels (LUMC) & Mirko de Melis (Medtronic)

1. EmbRACE: Electro-Molecular Basis and theRapeutic management of Atrial Cardiomyopathy, fibrillation and associated outcomEst - Uli Schotten MU, EmbRACE

2. Staging of Atrial Fibrillation by high resolution mapping - Natasja de Groot, Erasmus MC,CVON AFFIP and NWA-Circular

3. Biomarkers of atrial fibrillation - Bianca Brundel, Amsterdam UMC, CVON AFFIP and NWA Circular

4. Multimorbidity increases symptom severity and impacts risk of AF progression in patients with paroxysmal AF - Colinda van Deutekom, UMCG, RACE V

5. Predictors and patterns of late post-operative AF in the RACE V Tissue Bank Project - Michal Kawczynski MU, RACE V.


Chairs: Pieter Doevendans (UMC Utrecht, NLHI) & Jan Willem Buikema (Amsterdam UMC)

1. Innovation in animal free models of tachyarrhythmias and heart failure - Yannick Taverne, Erasmus MC, CVON AFFIP, NWA Circular

2. Designing an ex vivo human heart tissue platform for the Netherlands - Jort van der Geest, UMC Utrecht

3. Current status of animal models and animal-free innovations - Jolanda van der Velden, Amsterdam UMC, Double Dose and Arena-Prime

4. The eye as a window to the heart - Stephane Heymans, Maastricht UMC, CVON Early HFPEF

5. Plasma extracellular vesicles for diagnosis of Chronic Coronary Syndrome - Barend Mol, UMC Utrecht

6. Human iPS-derived Disease Models of ATTR Cardiac Amyloidosis - Alain van Mil, UMC Utrecht


Chairs: Wouter Jukema (LUMC, NLHI) & Rudolf de Boer (Erasmus MC)

1. Single-cell T-cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T-cells - Ilze Bot, LACDR/ Leiden University, GENIUS II

2. Myeloid PHD2 cKO improves intraplaque angiogenesis and reduces vein graft disease - Thijs Sluiter, Leiden UMC

3. Cardiometabolic aspects of patients with atherosclerosis, how to come to the right individual patient treatment - Fabrice Martens, Amsterdam UMC

4. Role of stiffness in cardiovascular disease - Stephan Huveneers - Amsterdam UMC

5. Atherosclerosis from mice to men - Michal Mokry, UMCU


Chairs: Pieter Glijnis (Stichting PLN) & Rogier Veltrop (CARIM Maastricht)

1. Unleashing the canine DCM model - Frank G. van Steenbeek, Utrecht University, DCVA-Double Dose

2. High-throughput contractility and kinome analysis identified cell cycle kinases and EGFR/IGF1R signaling as modulators of relaxation in healthy and hypertrophic cardiomyopathy cardiomyocytes - Diederik Kuster , Amsterdam UMC, Double Dose

3. Phenotypic modifiers in genetic cardiomyopathies - Job Verdonschot, MUMC, Double Dose

4. Targeting the microtubule network to prevent cardiac arrhythmias - Giovanna Nasilli, PhD student, Amsterdam UMC, PREDICT2

5. Loss-of-function variants in POPDC2 cause a novel autosomal recessive syndrome with sinus node disease and AV conduction defects in combination with hypertrophic cardiomyopathy - Najim Lahrouchi, Amsterdam UMC


Chairs: Kevin Vernooy (Maastricht UMC) & Pim van der Harst (UMC Utrecht)

1. Telerehabilitation in patients with acute heart failure: The new standard - Mayke van Leunen, Eindhoven University of Technology, Máxima Medical Centre, eMTIC

2. Clinical validation of video-based vital signs monitoring in ICU patients - Iris Cramer, Catharina Ziekenhuis, FORSEE

3. Bridging the gap: A guide to developing inclusive interventions - Isra al-Dhahir, Universiteit Leiden, Landelijk Netwerk: Gezond Leven in een Gezonde Omgeving

4. Remote monitoring of patients on left ventricular assist device (LVAD) support - Lieke Numan, UMC Utrecht

5. The miniECG: how much can we see in the heart? - Alejandra Zepeda Echavarria


Chairs: Joost Sluijter (UMC Utrecht) & Geert Boink (Amsterdam UMC)

1. Lipid nanoparticles for mRNA delivery to the heart - Clara Labonia, UMC Utrecht

2. Epicardial delivery of antimiR-195 via UPy-PEG-RCP hydrogel in a porcine model of acute ischaemic injury - Klaus Neef, UMCU, CVON REMAIN

3. t.b.d.

4. Gene therapy with engineered extracellular vesicles - Zhiyiong Lei, UMC Utrecht, PSIDER

5. Gene editing to cure heart failure - Simon Lebek, Olson Lab (Dallas), ArneA Prima


Chairs: Ellen Dirkx (Novo Nordisk) and Peter van der Meer (UMC Groningen)

1. Reshaping heart failure management: a role for precision medicine - Alicia Uijl, Amsterdam UMC, HEART4DATA

2. Preventing Chemotherapy-Induced Cardiac Dysfunction via the Circadian Clock - Linda van Laake, UMC Utrecht

3. Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the Netherlands: DECISION - Dirk Jan van Veldhuisen, UMC Groningen, Decision

4. natriuresis guided therapy in heart failure - Jozine ter Maaten, UMC Groningen, Double Dose

5. Successful start of the DCD heart transplantation program in the Netherlands - Niels van der Kaaij, UMC Utrecht, RegmedXB


Chairs: Harald Jorstad (Amsterdam UMC) & Douwe Atsma (LUMC)

1. Cold as a lifestyle strategy to comBAT cardiovascular diseases - Mariëtte Boon, Leids Universitair Medisch Centrum, GENIUS-II & COOLBAT

2. The impact of environmental pollution on cardiovascular health - Erik Timmermans, UMC Utrecht

3. A lifestyle monitoring system for cardiovascular care: Interim analysis of the Care-On clinical trial - Mayra Goevaerts, Eindhoven University of Technology / Máxima MC, CARE-ON

4. Implementation of very brief lifestyle advice within routine cardiac care - Renée IJzerman, Universiteit Leiden, Landelijk Netwerk: Gezond Leven in een Gezonde Omgeving

5. Toward Designing for Social Connectedness in Cardiovascular Disease Self-Care - Jhon Cerón-Guzmán, Eindhoven University of Technology, STRAP


Chairs: Anastasia Egorova (LUMC) & Hans Breur (UMC Utrecht)

1. Clinical course of TGA - Leo Engele, Amsterdam UMC, Outreach

2. Working out how to work out: effect of exercise on BAV and the Aorta - Roland van Kimmenade, Radboud UMC, Outreach

3. Systemic Right Ventricle Long-term Outcome (SINCERE): a multicentre study - Mohammad Mostafa Ansari Ramandi, UMC Groningen, Outreach

4. New insights into the pathophysiology of aortic valve stenosis coming from novel ex-vivo models - Maroua el Ouraoui, Leiden UMC

5. Pliable bioresorbable synthetic heart valve prostheses implanted in aortic position in sheep - Annemijn Vis, Amsterdam UMC, 1Valve


Chairs: Paul Volders (CARIM Maastricht) & Marta de Silva (LUMC)

1. Rare non-coding variation in SCN5A as a new contributor to Brugada Syndrome - Roddy Walsh, Amsterdam UMC, PREDICT2 and CONCORgenes

2. Update on the Dutch Idiopathic Ventricular Fibrillation Registry - Lisa Verheul, Maastricht UMC, Predict / Vigilance

3. Diagnostic Value of ECG-imaging in Ventricular Fibrillation - Matthijs Cluitmans, Maastricht UMC, Predict / Vigilance

4. Preventing Polymorphic Ventricular Tachycardia and Fibrillation by Drugs - Sami Viskin (Tel Aviv), Maastricht UMC, Predict / Vigilance ONLINE


Chairs: Stephane Heymans (Maastricht UMC) & Dirk Duncker (Erasmus MC)

1. Caroline Cheng, Utrecht UMC, RECONNEXT

2. Machine learning analyses of serial proteomics measurements in heart failure reveal dynamic subphenotypes and sex-specific protein profiles - Isabella Kardys, Erasmus MC

3. Improved mechanistic insights of HFpEF through in-silico translational studies - Tim van Loon, Maastricht University

4. Obesity-related Heart Failure: Insights from Proteomics - Navin Suthahar, Erasmus MC, SHE-PREDICTS HF

5. Systemic microvascular dysfunction in HFpEF among females and males - Jerremy Weerts, Maastricht UMC+, SHE-PREDICTS HF 2


Chairs: Niels van Royen (Radboudumc) & Eric Boersma (Erasmus MC)

1. The CLEAR CAD Trial - Nils Planken, Amsterdam UMC

2. Long-term prognosis after cardiac procedures: the opportunities and advantages of data linkage - Yvonne Koop, UMC Utrecht

3. Developing prognostic models to estimate 5-year atherosclerotic cardiovascular disease risk in South Limburg - Anke Bruninx, Maastricht University, CARRIER

4. Plasma Extracellular vesicles and prognosis of recurrent Major Adverse Cardiovascular Events - Dominique de Kleijn, UMC Utrecht, pERSUASIVE

5. Guideline Implementation and Quality of Care in Patients with Heart Failure: Rationale and Design of the TITRATE-HF Registry - Pascal Clephas, Erasmus MC, HEART4DATA


Chairs: Frances de Man (Amsterdam UMC) & Paula da Costa Martins (Maastricht University)

1. The evolving genetic landscape of pulmonary vascular disease - Dr. Matina Prapa (UK), St. Georges University Hospital, London UK

2. Non-coding RNA in right ventricle remodelling during pulmonary hypertension - Jordy Kocken, Maastricht University, Phaedra-Impact

3. Targeting BMP/TGFbeta signaling in the treatment of pulmonary vascular disease - Paul Yu, Brigham and Woman’s hospital (US) ONLINE

4. t.b.d.


Chairs: Steven Chamuleau (Amsterdam UMC) & Ibtihal Al Amri (LUMC)

1. Electrocardiography for coronary vascular dysfunction diagnosis in patients with angina without obstructive coronary artery disease - Diantha Schipaanboord, UMC Utrecht, IMPRESS

2. The correlation between the coronary and peripheral microvascular function in patients with angina and non-obstructive coronary artery disease - Janneke Woudstra, AmsterdamUMC, IMPRESS

3. Sex differences in outcome of distinct genetic DCM subgroups - Sophie Stroeks, Maastricht UMC, Double Dose

4. Low participation of women in cardiovascular trials: consequences and solutions from methodological perspective - Eric Boersma, Erasmus MC, IMPRESS


Chairs: Thijs van Osch (LUMC, HBCx) & t.b.d.

1. Assessing the link between cardiovascular health and cognition: Arterial Spin Labelling MRI-derived cerebrovascular brain age - Henk JMM Mutsaerts, MD PhD, Amsterdam UMC, collaborate with HBC, Dekker

2. Prehospital triage of patients with a suspected acute stroke: development, implementation and evaluation of a decision support tool - Ruben van de Wijdeven, Erasmus MC, CONTRAST 2.0

3. Towards a blood-based biomarker to differentiate stroke subtypes - Naomi Buntsma, Amsterdam UMC, CINTICS

4. Automatic TICI scoring in ischemic stroke patients - Ruisheng Su - Erasmus MC, CONTRAST


Chairs: Folkert Asselbergs (Amsterdam UMC) & Brigitte Evers-Roete

1. How to reduce the burden of Cardiovascular Disease: To screen or not to screen? - Ron Gansevoort, DCVA, Check@Home

2. Organized screening versus opportunistic screening? A GP view - Monika Hollander, UMC Utrecht

3. Jes Lindholt (DACANVAS), Denmark

4. Optimizing risk factor management in current AF care - Martin Hemels MD PhD FEHRA FESC, Rijnstate Hospital and Radboud UMC, CUSTOM-AF, Check@home and EMBRACE

We are happy to announce that the program of the 7th DCVA NLHI Translational Cardiovascular Research Meeting is acknowledged by the Netherlands Society Of Cardiology (NVVC).

Cardiologists will receive:

4 accreditation points for joining the program on Thursday June 22
7 accreditation points for joining theprogram on Friday June 23
Application for these accreditation points can be done during the registration process.

Click here to go to the registration form.

Every year the Netherlands Heart Institute awards fellowships to young scientists, allowing them to work abroad for up to a year. The fellowship program is supported by the Foundation Friends of Cardiology (Vrienden van de Cardiologie)

During the 7th Translational Cardiovascular Research Meeting of the DCVA and the Netherlands Heart Institute, three applicants will be invited to present their proposal. The awarding session will be during the closing session on Friday the 23rd of June 2023.

We are thrilled to announce the candidates for the upcoming 2023 fellowship program 🎉

Meet our candidates and their research proposals:
👥 Karel Breeman (Amsterdam UMC) “Leadless pacemakers: long-term outcomes and novel applications in order to minimize the burden of pacemaker-related complications”

👥 Renee Maas (UMC Utrecht) “ASSAY; Automated Stratification Scoring Analysis in Patient-derived cardiomYocytes”

👥 Mitchel M.(Amsterdam UMC) “Artificial intelligence to support risk stratification and clinical decision making in patients with obstructive coronary artery disease”

All candidates will present their proposals during the 7th DCVA NLHI Translational Cardiovascular Research Meeting on Thursday 22nd June and the awarding session will take place on Friday 23rd June.

During the 7th Translational Cardiovascular Research Meeting (on Friday the 23rd of June), the NLHI NVVC Einthoven Dissertation prizes will be awarded. Anyone who got his/her doctoral degree in 2022 in the Netherlands on a cardiovascular topic could compete for this prize.

The jury has selected the following 3 candidates:

  • Aernoud Fiolet: ‘Colchicine in Coronary Disease. Using the available to enable the sustainable’
  • Michiel Henkens: ‘Improving diagnosis and risk stratification of cardiomyopathies across the ejection fraction spectrum – The past, present and future’
  • Jorrit Lemkes: ‘Timing of coronary angiography in acute coronary syndromes – The TRANSIENT and COACT trial,

The candidates will present their thesis on Friday the 23rd of June during the morning session (8:45 - 9:25). The awarding session will be on the same day in the afternoon during the closing session (start at 16:15).

At the 7th Translational Cardiovascular Research Meeting (22-23 June), young researchers will have the opportunity to present and discuss their most exciting and recent data with key leaders in the cardiovascular field. The best presentations will be awarded poster prizes (€300, €200 and €100).

Interested? Please submit your abstract (no more than 300 words) by June 9th, 2023 via this link.

A maximum of 35 posters will be accepted and presented. From those 35 posters 10 outstanding candidates will be selected to present their posters during the moderated poster session (June 23rd).

We can’t wait to see the innovative research you have to share so don’t wait until the last minute and submit your poster here. First in, first served. The call will be closed after 35 submissions.

Abstracts will be selected by their quality before June 16th, 2023. A maximum of 10 candidates will be invited to present their work as a moderated poster session during lunch on Friday 23rd of June (12:25-13:25), and three winners will be chosen and honored during the closing session (16:15-17:30).


Read More

© 2024 Oscar Prent Assurantiën BV 
© 2024 | DCVA
Design & development:
Design & Bouw door: